Polymorphisms of RAD51 (RAD51-G135C) and XRCC3 (XRCC3-Thr241Met) double-strand break repair genes were increased both in de novo and particularly therapy-induced AML in a study that included both adults and children. The gene discussed is RAD51; the disease is acute myeloid leukemia.